Apr. 25 2025
Source Page: Leniolisib for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and overApr. 24 2025
Source Page: Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive, HER2-negative early breast cancer [ID6153]Apr. 24 2025
Source Page: Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive, HER2-negative early breast cancer [ID6153]Apr. 24 2025
Source Page: Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive, HER2-negative early breast cancer [ID6153]Apr. 24 2025
Source Page: Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive, HER2-negative early breast cancer [ID6153]Apr. 24 2025
Source Page: Compression products for treating venous leg ulcers: late stage assessmentApr. 24 2025
Source Page: Compression products for treating venous leg ulcers: late stage assessmentApr. 24 2025
Source Page: Compression products for treating venous leg ulcers: late stage assessmentApr. 24 2025
Source Page: Compression products for treating venous leg ulcers: late stage assessmentApr. 24 2025
Source Page: Dupilumab for treating moderate to severe chronic obstructive pulmonary disease ID6235